INSIGHTS ON DRUG DISCOVERY
-
![Three Success Factors To Accelerate Your Program To Clinical Trial_Siegfried]( "Three Success Factors To Accelerate Your Program To Clinical Trial")
Three Success Factors To Accelerate Your Program To Clinical TrialAccelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.
-
![Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries]( "Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries")
Unlocking Challenging Targets With Macrocycle DNA-Encoded LibrariesDiscover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.
-
![GettyImages-2178790629 cell]( "Improving Bioprocessing Outcomes With The CHOZN® Elite Host Cell Line")
Improving Bioprocessing Outcomes With The CHOZN® Elite Host Cell LineAccelerate cell line development with a host engineered for high expression, streamlined clone selection, flexible gene integration, and scalable industrial performance.
-
![GettyImages-2151620900 antibody, IgG]( "Discovery, Characterization Of Epitope-Diverse MMR Protein Antibodies")
Discovery, Characterization Of Epitope-Diverse MMR Protein AntibodiesLearn how these high-affinity, epitope-diverse mAbs provide a powerful toolkit to dissect the role of DNA mismatch repair (MMR) proteins in HD.
-
Mammalian Expression5/28/2026
See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.
-
Balancing Timelines In Outsourced R&D With GXP Compliance5/27/2026
Outsourced R&D balances speed and quality by integrating strong governance, clear planning, and GXP compliance, enabling efficient execution while reducing risk, rework, and development delays.
-
Integrated Drug Discovery: Hit To PCC In 16 Months5/8/2026
Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
Mammalian Cell Line Development3/26/2026
Explores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.
DRUG DISCOVERY SOLUTIONS
-
![GettyImages-1224202684-laboratory-dna-scientist-research-monitoring]( "TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction")
With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.
-
![GettyImages-2257501711-lab-data-scientist-operations]( "Custom Synthesis Services")
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
![Asimov - LVEdge]( "LV Edge System")
By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.
-
![molecular biology, scientific research-GettyImages-2209677305]( "Structural Biology Services")
At Curia, our team of expert protein chemists and structural biologists brings the advanced experience and technology needed to support all your structural biology services needs.
-
![drug-product-GettyImages-1293772880]( "Hybridoma Services")
Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.
